Stock DEVA HOLDING A.S.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Deva Holding A.S. Borsa Istanbul

Equities

TRADEVAW91E2

Pharmaceuticals

End-of-day quote Borsa Istanbul
Other stock markets
- TRY - Intraday chart for Deva Holding A.S.
Feb. 12 Tod's rises 17% on L Catterton bids to help owner's delisting plan RE
2023 Deva Holding A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Deva Holding AS is a Turkey-based pharmaceutical company that is primarily engaged in the production and marketing of finished pharmaceutical products, pharmaceutical ingredients and veterinary products, as well as animal health products, among others. The Company has four production facilities in Turkey. Its production facilities include the Tokapi, Cerezkoy I, Cerezkoy II and Kartepe production plants. The Company’s product portfolio comprises 73 drugs, which are available on the market in 177 various forms. It offers products, such as Azitro, Alemax, Cefax, Inhibace, Imatis, Hydrea, Kardozin, Kristapen, Magcar, Magnesie Calcinee, Nostil, Oceral, Remidon, Prolixin and Quet, among others. The Company has two subsidiaries, namely Vetaa Veteriner ve Tarim Ilaclari A.S. and Deva Holding NZ Ltd.

Sales per Business

TRY in Million2021Weight2022Weight Delta
Human Medicine
94.2 %
2,139 91.8 % 4,217 94.2 % +97.17%
Veterinary and Pesticides
5.0 %
161 6.9 % 226 5.0 % +40.19%
Other
0.8 %
31 1.3 % 35 0.8 % +15.54%

Sales per region

TRY in Million2021Weight2022Weight Delta
Turkey
100.0 %
2,330 100.0 % 4,478 100.0 % +92.15%

Managers

Managers TitleAgeSince
Philipp Haas CEO
 Chief Executive Officer - 06-07-13
Mesut Çetin DFI
 Director of Finance/CFO 45 08-03-13
Altug Uysal CTO
 Chief Tech/Sci/R&D Officer - -
Tijen Kavlak IRO
 Public Communications Contact - 09-02-28
Gülseren Mahmutoglu IRO
 Public Communications Contact - -
Riza Yildiz IRO
 Public Communications Contact - -

Members of the board

Members of the board TitleAgeSince
Philipp Haas CEO
 Chief Executive Officer - 06-07-13
Mesut Çetin DFI
 Director of Finance/CFO 45 08-03-13
Aysecik Haas BRD
 Director/Board Member - 13-05-21
Esref Günes Ufuk BRD
 Director/Board Member - 18-09-26
Sengül Soytas BRD
 Director/Board Member - 21-03-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 200,019,288 35,575,240 ( 17.79 %) 28,847 ( 0.0144 %) 17.79 %

Shareholders

NameEquities%Valuation
Eastpharma Ltd.
82.20 %
164,424,760 82.20 % 363 M ₺
Ashmore Portföy Yönetimi AS
0.0440 %
88,000 0.0440 % 194 350 ₺
Dimensional Fund Advisors Ltd.
0.0159 %
31,713 0.0159 % 70 039 ₺
AK Asset Management AS
0.007499 %
15,000 0.007499 % 33 128 ₺
Pensionskassernes Administration A/S
0.006210 %
12,422 0.006210 % 27 434 ₺
Amundi Asset Management SA (Investment Management)
0.001937 %
3,874 0.001937 % 8 556 ₺
DFA Australia Ltd.
0.000810 %
1,621 0.000810 % 3 580 ₺

Company contact information

Deva Holding AS

Halkali Merkez Mah. Basin Ekspres Caddesi No: 1

34303, Istanbul

+90 212 692 92 92

http://www.deva.com.tr
address Deva Holding A.S.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. DEVA Stock
  4. Stock
  5. Company Deva Holding A.S.